Status:
COMPLETED
Effect of Stellate Ganglion Block Combined With Facial Nerve Block on the Treatment of Idiopathic Facial Paralysis
Lead Sponsor:
Zhuan Zhang
Conditions:
Peripheral Facial Palsy
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Peripheral facial palsy is caused by damage to the facial nerve at any site of the peripheral branches after the facial nucleus.Stellate ganglion block is performed to treat peripheral facial palsy be...
Eligibility Criteria
Inclusion
- Diagnosed by clinical and neurological assessment as one-sided simple facial
- Age 18 to 75 years
- HBGS above Ⅳ
- the course of IFP not over 7 days.
Exclusion
- Coagulation dysfunction
- plate plate plate shape, quantity or abnormal function
- mental system diseases
- Gillan-Bahrain syndrome
- cancer, mumps, shingles infection, jaw facial pus lymph nodeitis, encephalitis, -cerebral hemorrhage and other diseases
- local infection or systemic infectious disease at the puncture site
- can not accept to nerve block
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04800666
Start Date
March 1 2021
End Date
March 30 2022
Last Update
November 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Affiliated Hospital of Yangzhou University
Yangzhou, Jiangsu, China